San Diego’s biggest venture capital deal of 2024 wasn’t an AI-driven firm or a biotech company. It wasn’t even a high tech startup. It was Vuori, the homegrown retail startup that’s valued ...

Story Feb. 4 - Turnstone Biologics: The San Diego biotech is seeking out “strategic alternatives” for its business and as it cuts work on its remaining pipeline program, the company is also ...

Pfizer sold the five-building facility on Science Center Drive in Torrey Pines to BioMed Realty, a San Diego-based firm owned ...

Landmark Bio brings to Artis state-of-the-art infrastructure and expertise in process development, analytical sciences, and ...

Swiss pharmaceutical giant Novartis announced Thursday that it plans to build a $1.1 billion research hub in San Diego as ...

Pfizer is officially bidding adieu to its sprawling research site in San Diego as it readjusts its local footprint and moves into a new site. | The company is moving its oncology R&D digs in San Diego ...

It is part of a planned $23 billion investment over the next five years aimed at expanding its U.S.-based infrastructure.

SAN DIEGO (FOX 5/KUSI) — Swiss pharmaceutical company, Novartis, has announced plans to build a new, $1.1 billion biomedical research complex in San Diego as part of a wider effort to expand its ...

Quantumzyme Corp. (OTC: QTZM), a biotechnology company leveraging computational enzyme engineering, is providing insight into the company's enzymatic design capabilities and current areas of ...

Last year, the San Diego-based Emlyn Group surveyed 250 biotechnology companies in the United States and Canada and received responses from 23 firms. The results of the study were released earlier ...

Pharmaceutical companies breathed a sigh of relief on Wednesday, but the tariff reprieve could prove fleeting.